Key Requirements
An exciting position has arisen within the Drug Development Unit (DDU) in the Division of Clinical Studies at the Institute of Cancer Research and Royal Marsden Hospital. We are a rapidly expanding, world class Phase 1 clinical trials unit based within the Royal Marsden Hospital, for the development of novel cancer therapeutics in early phase clinical trials which we believe will improve the care of cancer patients.
We are looking for a Personal Assistant, to support Professor Juanita Lopez within the Drug Development Unit. The post holder is required to provide assistance with managing schedules, handling and responding to correspondences, making travel & hotel arrangements, organising conferences and meetings, preparing documentation & taking minutes where appropriate. In addition, the post holder is also required to provide general administrative support to the operations within the DDU.
We encourage all applicants to access the job pack attached for more detailed information regarding this role.
Appointment will be on a one-year contract in the first instance. To apply for this post, please submit a CV and complete a supporting statement detailing reasons why you are applying for the post. All applications must be submitted online, via the e-recruitment system. Please click on the apply button and follow the instructions.
Due to the high volumes of applications we receive, we reserve the right to close the advert before the published closing date once we have received a sufficient number of applications. Therefore, we advise that you to submit your application, as early as possible to avoid disappointment.
Department/Directorate Information
The Drug Development Unit, (DDU) at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, is a world-leading centre for early-phase oncology trials, translating cutting-edge science into first-in-human clinical trials.
Through close integration of laboratory and clinical expertise, the Unit supports the functions of sponsoring early phase trials through Investigator Initiated Trials Team, as well as, delivers academic and industry sponsored trials.
Our mission is to fast-track the development of anti-cancer drugs, designed and synthesised at The ICR, or developed by CRUK scientists, or developed by industry collaborators, in order to rapidly impact the care of cancer patients. The DDU has been involved in the development of many hundreds of novel agents including several practice-changing cancer drugs.
The DDU is one of the Experimental Cancer Medicine Centres in the UK, part of the CRUK Convergence Science Centre and the Early Phase Drug Development Theme within the ICR-RM NIHR Biomedical Research Centre (BRC). The DDU has multiple academic and industry collaborations both nationally and internationally, to optimally serve our patients. The Unit is led by Professor Johann de Bono and Professor Udai Banerji.